$ATI

Fields Kimberly A sold $5.7M of ATI

Fields Kimberly A (Chair, President and CEO) sold 24,845 shares of ATI INC (ATI) at an average of $231.19 ($228.32–$232.43, $5.74M total) across 5 trades on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fields Kimberly A
Published Aug 19, 2026, 9:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATI
Bearish
medium confidence
Mentioned
$ATI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATIBearishLow
01

Why it matters

The disclosed sale may influence short‑term sentiment but is unlikely to drive long‑term price movement.

02

Market read

Insider sell of $5.7M by ATI's CEO, a material but not market‑moving event.

03

What to watch

Potential upcoming capital raise or strategic transaction that prompted the insider to diversify holdings.

Relevance 5/10Novelty 7/10Timing: filed 2026‑08‑19, reflects sale on 2026‑08‑17

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan allows pre‑scheduled sales.

Company-level read

Ticker impact

$ATIBearishMedium confidence
Context

CEO Fields sold $5.7M of ATI shares via a 10b5‑1 plan on 2026‑08‑17.

Expected impact

Potential short‑term downward pressure on ATI stock.

Evidence & confidence

The sale represents 4.3% of the insider's post‑transaction holdings and is sizable for a single day, but it follows a pre‑arranged plan, limiting immediate informational advantage.

Market effects

Minimal; the sale does not affect the broader specialty metals sector.

Limited to U.S. investors tracking insider activity.

Low; no cross‑border implications.

Counterpoint

The sale could be purely liquidity‑driven under a 10b5‑1 plan, not a bearish signal.

Key entities

  • Fields Kimberly A

    Chair, President and CEO of ATI Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATIMed

How Investors Are Reacting To ATI (ATI) Record Backlog And Raised Guidance

ATI Inc. raised its 2026 adjusted EBITDA and free cash flow guidance, citing record backlog and strong aerospace and defense demand. The company's updated outlook includes high teens defense growth, reinforcing its long-cycle thesis. ATI's share price is up 64% year-to-date, outpacing its industry group. Key risks include execution challenges and softer demand in industrial and medical sectors.

$ATIMed

ATI Shares Surge 64% YTD: What's Driving the Momentum?

ATI Inc. shares have surged 64% year to date, outperforming the aerospace-defense industry and S&P 500. The company reports strong aerospace and defense demand, a record backlog, and improved profitability. Q2 2026 jet-engine revenue rose 13%, defense sales increased 36% to $162M, and adjusted EBITDA grew 37% to $284.4M. ATI raised its 2026 adjusted EBITDA outlook to $1.135-$1.185B and adjusted free cash flow guidance to $550-$600M.

$ATIMed

4 Top Aerospace & Defense Stocks to Consider as America Commemorates 9/11

Four aerospace and defense stocks (ATI, DCO, IA, LOAR) are highlighted as Strong Buys by Zacks, with strong Q2 earnings and raised guidance. ATI reported $1.26B in sales (+10% YoY), record backlog of $4.4B, and raised 2026 EPS guidance. DCO saw record revenue of $224.5M (+11% YoY) and adjusted EPS of $1.18 (+34% YoY). IA reported $26.7M in sales (+11% YoY) and doubled adjusted EPS to $0.33. LOAR posted $171.6M in sales (+39% YoY) and raised 2026 EPS outlook.

$ATIMed

Extended Strategic Agreements to Support Management’s Full-Year 2026 Guidance Raise for ATI Inc. (ATI)

ATI Inc. (NYSE:ATI) raised its 2026 guidance after Q2 revenue rose 11% YoY to $1.26B, with adjusted EBITDA at $284.4M. The company secured long-term supply deals with BWX Technologies and Boeing, supporting its bullish outlook. However, risks include customer concentration and raw material cost volatility. Analysts remain bullish, with a consensus target price of $255.

$ATIMedAI 9/10

ATI’s (ATI) Record Backlog And Raised Guidance Signal Bigger Ambitions

ATI Inc. (NYSE:ATI) reported Q2 sales of $1.26B, up 11% YoY, with net income rising 50% to $151M. The company raised its full-year 2026 outlook, citing strong demand in aerospace and defense. ATI's backlog reached a record $4.4B, up 18% YoY. CEO Kimberly Fields noted demand outpacing supply, and the company repurchased $50M in shares. However, margins in one segment slipped, and debt increased to fund growth.

$ATIMed

Here's How Much a $1000 Investment in ATI Made 10 Years Ago Would Be Worth Today

ATI Inc., a Pittsburgh-based specialty materials producer, restructured in 2013 and 2020, focusing on High-Performance Materials & Components and Advanced Alloys & Solutions. In Q1 2026, earnings beat estimates but revenues missed. The company benefits from aerospace and defense demand but faces risks from production ramps and supply-chain issues.